FDA NDC Directory · JSON-LD · Markdown

Polymyxin B

NDC 55150-234 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Labeler / ManufacturerEugia US LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA206589
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAMUSCULAR INTRATHECAL INTRAVENOUS OPHTHALMIC
Active ingredientsPOLYMYXIN B SULFATE (500000 [USP'U]/1)
Marketing started20160404
Package count1

External sources

Source: openFDA. Public-domain (CC0).